Skip to main navigation Skip to search Skip to main content

MEDDAY: Effect of MD1003 in Progressive Multiple Sclerosis: A Randomized Double-Blind Placebo Controlled Study

Project: Research

Project Details

StatusFinished
Effective start/end date01/23/1711/12/21

Funding

  • Parexel International LLC: $214,747.00